SNHG11: A Non-Coding RNA Molecule as A Potential Drug Target and Biomarker

Target Name: SNHG11

NCBI ID: G128439

SNHG11

Other Name(s): LINC00101 | small nucleolar RNA host gene 11 | C20orf198 | NCRNA00101 | Small nucleolar RNA host gene 11

SNHG11: A Non-Coding RNA Molecule as A Potential Drug Target and Biomarker

SNHG11 (LINC00101) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of cell proliferation and has been shown to play a role in the development and progression of various diseases, including cancer.

SNHG11 is expressed in a variety of tissues and cells, including the brain, pancreas, and gastrointestinal tract. It has been shown to be involved in the regulation of cell cycle progression, apoptosis, and inflammation. It is also known to play a role in the development and progression of various diseases, including cancer.

One of the most promising aspects of SNHG11 is its potential as a drug target. Researchers have identified several potential drug candidates that target SNHG11, including small molecules, peptides, and antibodies. These compounds have been shown to have a variety of biological effects, including inhibiting cell proliferation, reducing inflammation, and modulating the expression of other genes.

In addition to its potential as a drug target, SNHG11 has also been identified as a potential biomarker. Its expression has been shown to be altered in a variety of diseases, including cancer, and it has been used as a biomarker in a variety of clinical trials. For example, studies have shown that SNHG11 levels are often elevated in cancer tissues and that inhibiting SNHG11 expression has been shown to be effective in slowing the growth of cancer cells.

SNHG11 is also a promising candidate for use as a diagnostic biomarker. Its expression has been shown to be altered in a variety of diseases, including cancer, and it has been used in a variety of clinical trials as a potential diagnostic biomarker. For example, studies have shown that SNHG11 levels are often elevated in cancer tissues and that inhibiting SNHG11 expression has been shown to be effective in slowing the growth of cancer cells.

In conclusion, SNHG11 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its expression is involved in the regulation of cell cycle progression, apoptosis, and inflammation, and it has been shown to play a role in the development and progression of various diseases, including cancer. Its potential as a drug target and biomarker is still being explored, but its identification and characterization as a potential therapeutic target and diagnostic biomarker is promising.

Protein Name: Small Nucleolar RNA Host Gene 11

The "SNHG11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNHG11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets